SGLY Q3 2019 Earnings Significant EPS Miss Amid Undisclosed Revenue Figures CTXR Q4 2025 Earnings Missed Estimates Amid No Revenue Stock Rises GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain GLNG Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance BioVie Inc BIVI Q1 2026 Earnings Narrowing Losses and Clinical Progress Buoy Investor Sentiment United Security Bancshares UBFO Q4 2025 Earnings EPS of 019 Reported Stock Unchanged